Holen Sie sich die Stockscreener-App
217.28
0.96%
-2.245
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$219.53
Offen:
$219.08
24-Stunden-Volumen:
437.59K
Relative Volume:
0.12
Marktkapitalisierung:
$153.54B
Einnahmen:
$24.57B
Nettoeinkommen (Verlust:
$3.60B
KGV:
43.05
EPS:
5.0475
Netto-Cashflow:
$5.25B
1W Leistung:
-1.00%
1M Leistung:
-7.62%
6M Leistung:
+9.24%
1J Leistung:
+2.49%
1-Tages-Spanne:
$217.13
$220.00
1-Wochen-Bereich:
$216.16
$226.03
52-Wochen-Spanne:
$171.00
$242.80
Danaher Corp Stock (DHR) Company Profile
Firmenname
Danaher Corp
Sektor
Branche
Telefon
(202) 828-0850
Adresse
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Vergleichen Sie DHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
217.20 | 155.19B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
TMO
Thermo Fisher Scientific Inc
|
551.69 | 212.36B | 44.56B | 6.73B | 6.29B | 17.74 |
|
IDXX
Idexx Laboratories Inc
|
636.36 | 51.34B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
131.14 | 37.70B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
185.13 | 34.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2025-03-14 | Hochstufung | Stifel | Hold → Buy |
| 2025-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-31 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-13 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2023-12-07 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-01 | Eingeleitet | SVB Securities | Outperform |
| 2023-04-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-24 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-17 | Fortgesetzt | Bernstein | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-06-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Eingeleitet | Bernstein | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Buy |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-04-07 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-03 | Fortgesetzt | Barclays | Overweight |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Fortgesetzt | Stifel | Hold |
| 2019-10-28 | Bestätigt | Needham | Buy |
| 2019-10-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-19 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2019-02-25 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-04-20 | Bestätigt | Stifel | Buy |
Alle ansehen
Danaher Corp Aktie (DHR) Neueste Nachrichten
The Evolution of a Compounder: A Deep-Dive Into Fortive Corp (FTV) - The Chronicle-Journal
Bessemer Group Inc. Raises Position in Danaher Corporation $DHR - MarketBeat
ABN AMRO Bank N.V. Makes New $7.27 Million Investment in Danaher Corporation $DHR - MarketBeat
Border to Coast Pensions Partnership Ltd Raises Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (DHR): A Bull Case Theory - Finviz
Danaher Corporation $DHR Shares Purchased by Machina Capital S.A.S. - MarketBeat
Jones Financial Companies Lllp Has $26.94 Million Holdings in Danaher Corporation $DHR - MarketBeat
The Top 5 Analyst Questions From Danaher's Q4 Earnings Call - Finviz
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Earnings call transcript: Danaher Q4 2025 earnings beat forecasts, stock dips - Investing.com
Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade - TechStock²
Downstream Processing Market By Top Trending Companies- GE - openPR.com
Danaher Corporation $DHR Shares Purchased by AlphaQuest LLC - MarketBeat
Danaher Corporation (NYSE:DHR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Danaher Corporation $DHR Shares Acquired by Principal Financial Group Inc. - MarketBeat
UMB Bank n.a. Sells 4,940 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Danaher Corporation $DHR Shares Purchased by Private Wealth Partners LLC - MarketBeat
Bryn Mawr Trust Advisors LLC Grows Position in Danaher Corporation $DHR - MarketBeat
Federated Hermes Inc. Cuts Holdings in Danaher Corporation $DHR - MarketBeat
Welch & Forbes LLC Sells 72,790 Shares of Danaher Corporation $DHR - MarketBeat
National Pension Service Has $286.76 Million Holdings in Danaher Corporation $DHR - MarketBeat
Keybank National Association OH Trims Stake in Danaher Corporation $DHR - MarketBeat
Pittenger & Anderson Inc. Lowers Position in Danaher Corporation $DHR - MarketBeat
Nan Fung Trinity HK Ltd. Invests $11.72 Million in Danaher Corporation $DHR - MarketBeat
Danaher Invests In Automata To Deepen AI Driven Lab Workflows - Yahoo Finance UK
UBS Reaffirms Their Buy Rating on Danaher (DHR) - The Globe and Mail
Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus - TechStock²
Automata secures $45M in series C raise - BioWorld MedTech
The Goldman Sachs Group Has Lowered Expectations for Danaher (NYSE:DHR) Stock Price - MarketBeat
Town & Country Bank & Trust CO dba First Bankers Trust CO Sells 5,515 Shares of Danaher Corporation $DHR - MarketBeat
TD Waterhouse Canada Inc. Sells 12,166 Shares of Danaher Corporation $DHR - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys 14,108 Shares of Danaher Corporation $DHR - MarketBeat
Automated Sample Preparation Research Report 2026 - GlobeNewswire Inc.
DHR Stock Price, Forecast & Analysis | DANAHER CORP (NYSE:DHR) - Chartmill
JPMorgan Chase & Co. Increases Danaher (NYSE:DHR) Price Target to $275.00 - MarketBeat
Danaher Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) - Benzinga
Jefferies Raises Price Target for Danaher (DHR) to $265, Maintai - GuruFocus
DHR Q4 Deep Dive: Bioprocessing and Diagnostics Drive Steady Performance Amid Muted End Markets - Finviz
Global Medical Radiation Detection Devices Market to Increase at a Steady Growth Rate of ~7% by 2032 | DelveInsight - GlobeNewswire Inc.
Danaher stock rating reiterated at Buy by TD Cowen despite guidance pressure - Investing.com Canada
2026-01-29 | Danaher Corporation (DHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:DHR | Press Release - Stockhouse
Danaher stock rating reiterated at Overweight by KeyBanc on bioprocess growth - Investing.com
Danaher Corporation (NYSE:DHR) Q4 2025 Earnings Call Transcript - Insider Monkey
New York State Common Retirement Fund Has $157.85 Million Holdings in Danaher Corporation $DHR - MarketBeat
Truist Financial Corp Has $64.75 Million Holdings in Danaher Corporation $DHR - MarketBeat
Flossbach Von Storch SE Cuts Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Eos Management L.P. - MarketBeat
Danaher Q4 2025 slides: revenue growth solid despite margin pressure By Investing.com - Investing.com Nigeria
Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line” - TechStock²
Top Industrial Stocks To Watch TodayJanuary 28th - MarketBeat
Finanzdaten der Danaher Corp-Aktie (DHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.28%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):